ACAAI 2016 Annual Scientific Meeting

November 10, 2016 to November 14, 2016

Practice Advancement

New times, New Treatments. New standards.

Target Audience

All practicing allergists/immunologists
Fellows in allergy/immunology training programs
Primary care physicians who care for allergy patients
Allied health professionals in the field of allergy and immunology

Learning Objectives

At the conclusion of this activity, participants should be able to:

Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract
Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency
Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases
Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases
Explain the impact of environmental exposures and external influences on patients with allergic disorders
Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health
Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes
Discuss processes, tools and technologies for the efficient allergy and immunology practice

Additional information

Disclosure:

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

Cem Akin, MD, PhD Consultant/Advisor: Blueprint Medicines, Novartis, Patara Pharma; Supported/Contracted Research: Dyax	Thomas B. Casale, MD, FACAAI Consultant/Advisor: AstraZeneca, Genentech, Novartis, Sanofi, Teva
Craig A. Alter, MD Consultant/Advisor: Pfizer	Bradley E. Chipps, MD, FACAAI Consultant/Advisor: AstraZeneca, Boehringer Ingelheim, Genentech, Merck, Novartis; Speaker: AstraZeneca, Boehringer Ingelheim, Genentech, Merck, Novartis; Supported/Contracted Research: Stallergenes
Leonard B. Bacharier, MD, FACAAI Consultant/Advisor: Boehringer Ingelheim, DBV Technologies, GlaxoSmithKline, Meda,Teva; Speaker: AstraZeneca, Novartis	Ray S. Davis, MD, FACAAI Consultant/Advisor: Alcon, AstraZeneca, Baxter, Meda, Merck, Teva
Mark M. Ballow, MD, FACAAI Consultant/Advisor: CSL Behring, Kedrion; Supported/ Contracted Research: CSL Behring; Speaker: Baxter	§ Chitra Dinakar, MD, FACAAI Consultant/Advisor: Aerocrine; Supported/Contracted Research: GlaxoSmithKline, Merck, Teva
Gregory W. Bensch, MD, FACAAI Consultant/Advisor: AstraZeneca, Teva; Supported/ Contracted Research: AstraZeneca, Boehringer Ingelheim, Pearl, Teva	Mark S. Dykewicz, MD, FACAAI Consultant/Advisor: Merck; Supported/Contracted Research: Novartis
J. Andrew Bird, MD, FACAAI Speaker: Nutrica; Supported/Contracted Research: Aimmune Therapeutics, DBV Technologies	David B. Engler, MD, FACAAI Stock: Regeneron
Mark Boguniewicz, MD, FACAAI Consultant/Advisor: Celgene, Regeneron; Supported/ Contracted Research: Anacor	Elizabeth A. Erwin, MD Stock: Pfizer
Larry Borish, MD, FACAAI Consultant/Advisor: Allakos, Knopp, Novartis, PluriStem	Stanley M. Fineman, MD, MBA, FACAAI Speaker: AstraZeneca, Genentech, Meda, Merck, Mylan; Supported/Contracted Research: Genentech, Meda
John C. Browning, MD, MBA Supported/Contracted Research: Anacor, MedImmune, Regeneron	David M. Fleisher, MD Consultant/Advisor: Food Allergy Research & Education, LabCorp, National Peanut Board, Receptors, Nestle Nutrition Institute; Supported/ Contracted Research: Monsanto Company, Nestle Nutrition Institute
A. Wesley Burks, MD, FACAAI Consultant/Advisor: Dynavax Technologies, Genentech, GLG Research, Intrexon, Perrigo, Perosphere, Regeneron, SRA International, Sanofi, Valeant; Board Member (for profit organization) Stallergenes	§ Luz S. Fonacier, MD, FACAAI Speaker: Baxter; Supported/Contracted Research: Baxter, Genentech, Merck
§ B. Gwen Carlton, DNP, APRN, FNP-BC Speaker: Genentech	David M. Lang, MD, FACAAI Consultant/Advisor: Genentech, GlaxoSmithKline, Meda, Merck; Speaker: Genentech; Supported/ Contracted Research: Genentech, Merck
Lene Heise Garvey, MD, PhD Consultant/Advisor: Merck; Speaker: Thermo Fisher Scientific	Bob Lanier, MD, FACAAI Supported/Contracted Research: Merck, Novartis, Teva; Speaker: Genentech, Merck
Maureen George, PhD, RN, AE-C Consultant/Advisor: Teva; Speaker: Teva	§ Phillip L. Lieberman, MD, FACAAI Consultant/Advisor: Genentech, Mylan, Teva, Valeant; Speaker: Meda
§ Richard G. Gower, MD, FACAAI Consultant/Advisor: CSL Behring, Dyax, Mylan, Shire, Teva; Medical Director: HollisterStier; Speaker: CSL Behring, Mylan, Shire, Teva; Supported/Contracted Research: Anacor, Biocryst, Circassia, CSL Behring, Dyax, Genentech, GlaxoSmithKline, Kedrion, Mylan, Optinose, Pearl, Regeneron, Shire, Teva; Stock: Merck	Peter A. Lio, MD Consultant/Advisor: Anacor, Galderma, Johnson & Johnson, Pierre Fabre, Valeant
David F. Graft, MD, FACAAI Consultant/Advisor: Aerocrine; Speaker: Merck	William R. Lumry, MD, FACAAI Consultant/Advisor: Biocryst, CSL Behring, Dyax, Shire; Speaker: CSL Behring, Dyax, Shire, Teva; Supported/ Contracted Research: ADMA Biologics, Biocryst, Circassia, CSL Behring, Dyax, Kedrion, Mylan, Novartis, Roche, Shire, Teva
Mitchell H. Grayson, MD, FACAAI Supported/Contracted Research: Polyphor	§ Todd A. Mahr, MD, FACAAI Speaker: Aerocrine, Genentech, GlaxoSmithKline, Meda, Merck, Mylan, Sanofi, Teva
§ Matthew Greenhawt, MD, MBA, MSc, FACAAI Consultant/Advisor: National Peanut Board; Supported/Contracted Research: National Center for Translational Sciences	Michael E. Manning, MD, FACAAI Consultant/Advisor: Dyax, Shire; Speaker: Baxter, CSL Behring, Dyax, Genentech, Merck, Shire; Supported/ Contracted Research: Amgen, AstraZeneca, Biocryst, Dyax, Genentech, Janssen, Johnson & Johnson, Merck, Novartis, Sanofi, Shire, Teva
Gary N. Gross, MD, FACAAI Supported/Contracted Amgen, Genentech, Janssen, Mylan, Perrigo, Sanofi, Teva; Speaker: Merck, Teva	Kelly M. Maples, MD, FACAAI Speaker: Teva
Ruchi Gupta, MD, MPH Speaker: Mylan Specialty; Supported/Contracted Research: Food Allergy Research & Education, Mylan	Gailen D. Marshall, MD, PhD, FACAAI Supported/Contracted Research: Amgen, AstraZeneca, National Institutes of Health (NIH)
Nicola A. Hanania, MD, MS Consultant/Advisor: AstraZeneca, Meda, Novartis, Pfizer, Roche, Sunovion; Speaker: Genentech; Supported/Contracted Research: Boehringer Ingelheim, Chiesi, Genentech, GlaxoSmithKline, Mylan, Novartis, Pfizer, Roche, Sunovion	• § Kevin P. McGrath, MD FACAAI Speaker: Teva
Mary Lou Hayden, MSN, FNP-BC, AE-C Consultant/Advisor: Boehringer Ingelheim, Mylan, Teva	J. Allen Meadows, MD, FACAAI Consultant/Advisor: Pfizer; Stocks: Johnson & Johnson
Erika Jensen-Jarolim, MD Speaker: Allergy Therapeutics, Meda, Roxall, Thermo Fisher Scientific; Stocks: Biomedical International R&D Vienna, AllergyCare Vienna	Eli O. Meltzer, MD, FACAAI Consultant/Advisor: AstraZeneca, Boehringer Ingelheim, Circassia, GlaxoSmithKline, Greer, Johnson & Johnson, McNeill, Meda, Merck, Regeneron, Sanofi, Sunovion, Teva, Takeda, Valeant; Speaker: Alcon, Greer, Meda, Mylan, Sunovion, Teva, Takeda
§ Rohit K. Katial, MD, FACAAI Consultant/Advisor: AstraZeneca, GlaxoSmithKline, Meda, Teva; Speaker: GlaxoSmithKline, Meda	Anthony Montanaro, MD, FACAAI Supported/Contracted Reearch: Circassia, Genentech, GlaxoSmithKline, Merck, Teva
§ David A. Khan, MD, FACAAI Speaker: Baxter, Genentech	Harold S. Nelson, MD, FACAAI Consultant/Advisor: AstraZeneca, Circassia, Merck, Pearl Therapeutics; Supported/Contracted Research: Circassia
Lisa K. Kobrynski, MD, MPH, FACAAI Supported/Contracted Research: Baxter; Speaker: Baxter, CSL Behring	William S. Silvers, MD, FACAAI Speaker: Teva
Jerald W. Koepke, MD, FACAAI Supported/Contracted Research: Sanofi	Roland Solensky, MD Supported/Contracted Research: AstraZeneca, Merck
Anna H. Nowak-Wegrzyn, MD, FACAAI Consultant/Advisor: Merck, Nestle; Speaker: Sanofi; Supported/Contracted Research: DBV Technologies, Food Allergy Research & Education, NIH/NIAID, ITN, Nutricia	§ Brett Stanaland, MD, FACAAI Speaker: Alcon, Meda, Merck, Teva
Talal M. Nsouli, MD, FACAAI Consultant/Advisor: Teva; Speaker: Perrigo, Thermo Fisher Scientific	§ James L. Sublett, MD, FACAAI Consultant/Advisor: Boston Scientific, Greer; Speaker: Genentech, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Supported/Contracted Research: Array BioPharma, AstraZeneca, Boehringer Ingelheim, Forest, Mylan, Sanofi: Stock: AllergyZone
§ Maeve E. O’Connor, MD, FACAAI Consultant/Advisor: Novartis; Speaker: Aerocrine, Baxter, Dyax, Greer, Meda, Merck, Mylan, Teva, Thermo Fisher Scientific	§ Stephen A. Tilles, MD, FACAAI Supported/Contracted Research: Amgen, Astellas, AstraZeneca, Biota, Circassia, DBV Technologies, Genentech, Merck, Mylan, Novartis, Perrigo, Teva
§ John J. Oppenheimer, MD, FACAAI Consultant/Advisor: GlaxoSmithKline, Meda, Mylan; Supported/Contracted Research: AstraZeneca, MedImmune, Novartis	James M. Tracy, DO, FACAAI Consultant/Advisor: Johnson and Johnson, Pfizer; Stock: Johnson & Johnson
Jordan S. Orange, MD, PhD, FACAAI Consultant/Advisor: ADMA Biologics, ASD Healthcare, Baxter, CSL Behring, Walgreens	Carina Venter, PhD, RD Consultant/Advisor: Mead Johnson, Nestle; Speaker: Nutricia; Supported/Contracted Research: Thermo Fisher Scientific
Reynold A. Panettieri, Jr., MD Consultant/Advisor: AstraZeneca, Johnson & Johnson; Supported/Contracted Research: Gilead, Johnson & Johnson, Merck, Roche, Sanofi	Christine W. Wagner, MSN, RN, CPNP, AE-C Speaker: Teva
Anju T. Peters, MD, FACAAI Consultant/Advisor: Baxter, Greer, Meda; Speaker: Celgene	Julie Wang, MD, FACAAI Consultant/Advisor: JDP Therapeutics, Merck
Stephen P. Peters, MD, PhD Consultant/Advisor: AstraZeneca, Boehringer Ingelheim, CSL Behring, Gilead, Merck, Novartis, Pfizer, Teva, PPD Development, Quintiles, Theron	Richard L. Wasserman, MD, PhD, FACAAI Consutlant/Advisor: ADMA Biologics, Baxter, Bio Products Lab, CSL Behring, Grifols, Kedrion, ProMetic, Therapure Biopharma; Speaker: Baxter, CSL Behring; Supported/Contracted Research: ADMA Biologics, Baxter, Bio Products Labs, CSL Behring, Kedrion, Merck, Perrigo, Sanofi, Teva
§ Michael Pistiner, MD, MMSc, FACAAI Stock: AllergyHome.org	Stephen I. Wasserman, MD, FACAAI President: ABAI; consultant(sp): Pathway Genomics
Jay M. Portnoy, MD, FACAAI Speaker: Mylan, Thermo Fisher Scientific	Richard W. Weber, MD, FACAAI Consultant/Advisor: Genentech; Speaker: AstraZeneca, Meda, Merck
Marc A. Riedl, MD, MS Consultant/Advisor: Baxter, BioCryst, CSL Behring, Dyax, Salix, Shire: Speaker: Baxter, CSL Behring, Dyax, Salix, Shire: Supported/Contracted Research: Amgen, Biocryst, CSL Behring, Dyax, Shire	Bruce L. Zuraw, MD, FACAAI Consultant/Advisor: BioCryst, CSL Behring, Dyax, Genentech, Isis, Novartis, Sanofi, Shire
§ Deidra H. Sanders, MSN, APRN, FNP-BC Consultant/Advisor: Meda; Stock: AllergyZone
§ Charles J. Siegel, MD, FACAAI Consultant/Advisor: Meda; Speaker: Meda, Teva

• = Planner §= Moderator

The following have no financial relationships to disclose:

Juan Adams, MD	Nabeel Farooqui, MD
Karla Adams, MD	Tracy Fausnight, MD, FACAAI
David B. Allen, MD	Alessandro Fiocchi, MD, FACAAI (SC)
§ Amal H. Assa’ad, MD, FACAAI	§ Michael B. Foggs, MD, FACAAI
§ Sami L. Bahna, MD, DrPH, FACAAI	§ Karen A. Freedle, MD, FACAAI
Aleena Banerji, MD	Theodore M. Freeman, MD, FACAAI
Charles Barnes, PhD	Marianne N. Frieri, MD, PhD, FACAAI
Rachel Bean, MD	Pinkus Goldberg, MD, FACAAI
Avraham Beigelman, MD	Paul A. Greenberger, MD, FACAAI
Joseph A. Bellanti, MD, FACAAI	Magdalena Grzyb, MD
• § Cheryl K. Bernstein, BSN, RN, CCRC	Malike Gupta, MD
• § David I. Bernstein, MD, FACAAI	Daniel L. Hamilos, MD, FACAAI
Leonard Bielory, MD, FACAAI	I. Celine Hanson, MD, FACAAI
§ Theresa A. Bingemann, MD, FACAAI	Jill Hanson, MD
Cheryl Blackwell, BSN, RN, AE-C	Curtis Hedberg, MD, FACAAI
Hannelore A. Brucker, MD, FACAAI (SC)	Alice Hoyt, MD
Paula Busse, MD	Fred H. Hsieh, MD, FACAAI
Ronna L. Campbell, MD, PhD	Kuan-Hsiang G. Huang, MD, PhD
Mariana C. Castells, MD, PhD, FACAAI	Yvonne Huang, MD
§ Helen Hei-ling Chan, MD, FACAAI	Elliot Israel, MD
Mirna Chehade, MD, MPH	• Charlotte M. Jacobsen, MSN, RN
Meng Chen, MD	Jaison Jose, DO
Robert Chiffelle, MHSA	Robert J. Karman, MD
Seong H. Cho, MD	Michael D. Keller, MD
Melanie Chong, MD	• John M. Kelso, MD, FACAAI
Christina E. Ciaccio, MD, MSc, FACAAI	Rebecca Koransky, MD
• Kimberly G. Clay, MN, APRN, FNP-BC	• Tao T. Le, MD, MHS, FACAAI
David E. Cohen, MD	§ Gerald B. Lee, MD
Kevin Cook, MD	Robert F. Lemanske, MD, FACAAI
• Mark L. Corbett, MD, FACAAI	• § James T. Li, MD, PhD, FACAAI
• Peter S. Creticos, MD	Samantha Lin, MD
Howard C. Crisp, MD	Baojuan Liu
Mark A. Davis-Lorton, MD, FACAAI	• § Bryan L. Martin, DO, FACAAI
Ves Dimov, MD	Fernando D. Martinez, MD
Nicholas Ditzler	Hannia Matt, MD
• § William K. Dolen, MD, FACAAI	Stephanie Mawhirt, DO
Steve Dorman, MD	Jacek Mazurek, MD
Dumitru Moldovan, MD	Peter C. Schalock, MD
• Kevin R. Murphy, MD, FACAAI (SC)	William T. Shearer, MD, PhD
Kari C. Nadeau, MD, PhD	Michael Sherenian, MD
Naveen Nannapaneni, MD	• § Jodi Shroba, MSN, APRN, CPNP
Maya Nanda, MD, MSc	Mili Shum, MD
Elham A. Nekoo, MD	William S. Silvers, MD
Michael R. Nelson, MD, PhD, FACAAI	David P. Skoner, MD, FACAAI
Victoria Nelson	Raymond S. Slavin, MD, FACAAI
• § Andrew Nickels, MD	• Sheldon L. Spector, MD, FACAAI
Noreen H. Nicol, PhD, RN, FNP, NEA-BC	Jonathan M. Spergel, MD, PhD, FACAAI
Irum Noor, DO	Sarah Spriet, DO
Lois M. Nora, MD, JD, MBA	Whitney Stevens, MD, PhD
Safa Nsouli, MD	Patricia H. Stewart, MD
Mark T. O’Hollaren, MD, FACAAI	James W. Sublett, MD, FACAAI
Grant C. Olson, MD, FACAAI	Michael S. Tankersley, MD, FACAAI
Roy A. Orden, MD	James S. Taylor, MD
Thamiris Palacios, DO	Mary C. Tobin, MD, FACAAI
Dipika R. Patel, MD	Stephen K. Tsui, PhD
Neha N. Patel, MD	Janna M. Tuck, MD, FACAAI
Priya Patel, MD	Joseph C. Turbyville MD, FACAAI
Sheenal Patel, MD	• Kay Tyler, BS, BA, MBA
David L. Patterson, MD, MBA, MS, FACAAI	Peter Vadas, MD, PhD
Tammy Peng, MD	• § Dana V. Wallace, MD, FACAAI
Maureen M. Petersen, MD, FACAAI	Kathryn R. Wessell, DO
Thomas A. Platts-Mills, MD, FACAAI	C. Ross Westley, MD, FACAAI
Brooke I. Polk, MD	Martha White, MD, FACAAI
Donald W. Pulver, MD, FACAAI	P. Brock Williams, PhD, FACAAI (SC)
Vijay Ramakrishnan, MD	Andrew Winslow, MD
Avner Reshef, MD	Priscilla Wong, MD
Lanny J. Rosenwasser, MD, FACAAI	Shijun Xi, MD
• John M. Routes, MD, FACAAI	Kenneth Yeager, PhD
Tara V. Saco, MD	Cherie Y. Zachary, MD, FACAAI
Steve Shah, MD	Myron Zitt, MD, FACAAI

• = Planner §= Moderator

• = Planner §= Moderator

Course summary

Available credit:

41.25 AMA PRA Category 1 Credit™
41.25 Attendance
13.50 MOC

Course opens:

11/10/2016

Course expires:

11/14/2016

Event starts:

11/10/2016 - 8:00am CST

Event ends:

11/14/2016 - 5:00pm CST

Add to calendar:

Moscone West Convention Center

San Francisco, CA

United States

All identified conflicts of interest have been resolved.

Grant Anhalt, PhD

Consultant/Advisory Board: GlaxoSmithKline

Noga Askenazi, MD FACAAI

Stock: Johnson and Johnson

Amal Assa'ad, MD, FACAAI

Consultant/Advisory Board: Mead Johnson; Research Grant: DBV Technologies, Genentech, GlaxoSmithKline, Teva

Leonard Bacharier, MD, FACAAI

Consultant/Advisory Board: DVB Technologies, Merck, Teva; Speaker: Aerocrine, GlaxoSmithKline, Merck

Sami L. Bahna, MD, DrPH, FACAAI

Consultant/Advisory Board: Abbott; Speaker: Abbott; Honorarium: Abbott

Gregory Bensch, MD, FACAAI

Consultant, Speaker: Teva; Speaker: AstraZeneca.

William E. Berger, MD, MBA, FACAAI

Consultant/Advisory Board: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Speaker: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva; Research Grant: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Novartis, Sunovion, Teva

Jonathan A. Bernstein, MD, FACAAI

Consultant/Advisory Board: CSL Behring, Dyax, Meda, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Meda, Shire, Teva, ViroPharma; Honorarium: CSL Behring, Dyax, Meda, Shire, Teva, Viropharma; Research Grant: CSL Behring, Dyax, Novartis, Shire, ViroPharma

Leonard Bielory, MD, FACAAI

Consultant/Advisory Board: Allergan, Bausch & Lomb, Merck, Pharmacal, Sanofi-Chattem; Speaker: Allergan, Bausch & Lomb, Merck; Honorarium: Allergan, Bausch & Lomb, Merck; Research Grant: Allergan, EPA; Stock: STARxTech

Clifton O. Bingham, III, MD

Consultant/Advisory Board: Abbvie, Amgen, Bristol-Myers Squibb, Celgene, Genentech, Roche, Janssen, Novartis, Novo Nordisk, Pfizer, UCB; Research Grant: Bristol-Myers Squibb, Janssen, UCB

Michael S. Blaiss, MD, FACAAI

Consultant/Advisory Board: Alcon, Allergan, Bausch & Lomb, Genentech, GlaxoSmithKline, JDP Therapeutics, Merck, Mylan, Pfizer, PMD Healthcare, Proctor & Gamble, Sanofi, Sunovion, Takeda, Teva; Speaker: Alcon, Allergan, AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Sunovion, Takeda

Don A. Bukstein, MD, FACAAI

Speaker: Aerocrine, AstraZeneca, Genentech, Merck, Novartis, Sunovion, Teva

A. Wesley Burks, MD, FACAAI

Consultant/Advisory Board: Dow AgroSciences, ExploraMed Development, Genalyte, Hycor, Mastcell Pharma, Merck, Nordic Biotech, Novartis, Perrigo Company, Regeneron, Unilever; Speaker: Mylan Specialty; Research Grant: Hycor; Stock: Allertein, Mylan Specialty

Peter A. Calabresi, MD

Consultant/Advisory Board: Abbott, Vertex; Honorarium: Abbott, Vertex; Research Grant: Abbott, Bayer, Biogen Idec, Novartis, Vertex

Warner W. Carr, MD, FACAAI

Consultant/Advisory Board: Alcon, Allergan, Indegene, Meda; Speaker: Alcon, AstraZeneca, Meda, Teva; Honorarium: Alcon, Allergan, AstraZeneca, Indegene, Meda, Teva; Research Grant: Adrea, Forest, Sunovion

Thomas B. Casale, MD, FACAAI

Consultant/Advisory Board: Genentech, Novartis

Adrian M. Casillas, MD, FACAAI

Research Grant: CSL Behring

Bradley E. Chipps, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Speaker: AstraZeneca, Bausch & Lomb, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion; Honorarium: AstraZeneca, Bausch & Lomb, Mylan Specialty, Genentech, GlaxoSmithKline, Merck, Novartis, Sunovion

Mark L. Corbett, MD, FACAAI

Speaker: AstraZeneca, Merck, Sunovion, Teva

Linda Cox, MD, FACAAI

Consultant/Advisory Board: Genentech, Stallergenes; Speaker: Stallergenes

Timothy M Craig, DO, FACAAI

Consultant/Advisory Board: CSL Behring, Dyax. Merck; Speaker: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Honorarium: CSL Behring, Dyax, Genentech/Novartis, Merck, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Genentech/Novartis, GlaxoSmithKline, Merck, Pharming, Shire, ViroPharma

Peter S. Creticos, MD

Consultant/Advisory Board: Circassia, Greer, Merck; Research Grant: Circassia, Greer, Merck

Chitra Dinakar, MD, FACCAI

Speaker: Aerocrine, Teva; Honorarium: Aerocrine, Teva

Paul Dowling, MD, FACAAI

Speaker: Research Grant: GlaxoSmithKline, Merck

Mark S. Dykewicz, MD, FACAAI

Consultant/Advisory Board: Merck; Honorarium: Merck

Daniel Ein, MD, FACAAI

Consultant/Advisory Board: Allergan

Renata Engler, MD, FACAAI

Research Grant: National Institutes of Health, Stock: Stellar Biotech

Stanley M. Fineman, MD, MBA, FACAAI

Speaker: AstraZeneca, Genentech/Novartis, Sunovion; Research Grant: Genentech/Novartis, Shionogi, Sunovion

Michael B. Foggs, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck; Speaker: AstraZeneca, GlaxoSmithKline, Merck; Honorarium: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Hycor, Merck

Luz S. Fonacier, MD, FACAAI

Speaker: Baxter; Honorarium: Genentech; Research Grant: Baxter, Dyax, Genentech, Merck

Pinkus Goldberg, FACAAI

Consultant/Advisory Board: Allergan; Speaker: Genentech, Meda, Merck, Mylan, Novartis; Research Grant: Circassia, Genentech, GlaxoSmithKline, Meda, Merck, Novartis, Teva

Richard G. Gower, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, CSL Behring, Mylan Specialty, Dyax, Genentech, HollisterStier, Mylan, Novartis, Roche, Sanofi, Shire, Teva, ViroPharma; Speaker: Bausch & Lomb, CSL Behring, Mylan, Genentech, Novartis, Roche, Shire, Teva, ViroPharma; Honorarium: Bausch & Lomb, CSL Behring, Genentech, Mylan, Novartis, Roche, Shire, Teva, ViroPharma; Research Grant: Bausch & Lomb, Boehringer Ingelheim, Circassia, CSL Behring, Eli Lilly, Genentech, GlaxoSmithKline, Green Cross, Kedrion, Mylan, Novartis, Pharming, Roche, Shire, Teva, ViroPharma; Stock: Merck

Matthew Greenhawt, MD, MBA, MSc

Consultant/Advisory Board: Nutricia; Research Grant: National Institutes of Health; Speaker: Nutricia; Honorarium: Nutricia

Vivian Hernandez-Trujillo, MD, FACAAI

Consultant/Advisory Board: Baxter, Merck, Sanofi; Speaker: Baxter, CSL Behring, Merck, Sanofi

Lewis Kanter, MD, FACAAI

Speaker: Alcon, Meda, Sunovion, Teva

Rohit K. Katial, MD, FACAAI

Consultant/Advisory Board: Teva; Honorarium: Teva

David A. Khan, MD, FACAAI

Speaker: Baxter, Genentech, Merck, ViroPharma; Honorarium: Baxter, Genentech, Merck, ViroPharma

Monica Kraft, MD

Research Grant: Boston Scientific, Eumedics, Genentech, GlaxoSmithKline, Merck, National Institutes of Health, Novartis

Charles J. Lane, MD

Speaker: GlaxoSmithKline; Honorarium: Mylan Specialty

Bobby Q. Lanier, MD, FACAAI

Consultant/Advisory Board: Merck, Novartis; Speaker: Merck, Novartis; Research Grant: Teva

James T. Li, MD, PhD, FACAAI

Stocks: Abbott, Johnson & Johnson, Novartis

Phillip L. Lieberman, MD, FACAAI

Consultant/Advisory Board: Meda, Mylan, Sanofi; Speaker: Meda, Mylan; Honorarium: Meda, Mylan

Todd A. Mahr, MD, FACAAI

Consultant/Advisory Board: Mylan, Sanofi; Speaker: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi; Honorarium: Aerocrine, Genentech, GlaxoSmithKline, Mylan, Sanofi

Lyndon Mansfield, MD, FACAAI

Consultant/Advisory Board: Genentech; Speaker: Sunovion, Teva

Gailen D. Marshall, Jr., MD, PhD, FACP, FACAAI

Research Grant: Teva, National Institutes of Health, Health Resources and Services Administration

Kevin P. McGrath, MD, FACAAI

Speaker: Sunovion

Travis A. Miller, MD, FACAAI

Consultant/Advisory Board: Meda, Sunovion; Speaker: Alcon, AstraZeneca, Bausch & Lomb, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion, Teva; Honorarium: Alcon, AstraZeneca, GlaxoSmithKline, Meda, Merck, Mylan, Novartis, Sunovion; Teva

Anthony Montanaro, MD, FACAAI

Research Grant: Boehringer Ingelheim, Genentech, GlaxoSmithKline, Merck, Novartis, Teva

Harold S. Nelson, MD, FACAAI

Consultant/Advisory Board: Merck, Shionogi: Honorarium: Merck, Pearl, Shionogi; Research Grant: Circassia, Lincoln Diagnostics, Rigel

Talal M. Nsouli, MD, FACAAI

Consultant/Advisory Board: Thermo Fisher Scientific, Sunovion, Teva; Speaker: Thermo Fisher Scientific, Sunovion, Teva

John J. Oppenheimer, MD, FACAAI

Consultant/Advisory Board: AstraZeneca, GlaxoSmithKline, Mylan, Sunovion; Research Grant: AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline

Nancy K. Ostrom, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Meda, Merck, Teva; Speaker: AstraZeneca, GlaxoSmithKline, Meda, Merck, Novartis, Sunovion, Teva; Research Grant: Apotex, AstraZeneca, Boehringer Ingelheim, ElectroCore, GlaxoSmithKline, MedImmune, Merck, Nestle, Novartis, Rigel, Sunovion, Teva, Actavis

Thomas A.E. Platts-Mills, MD, PhD, FACAAI

Consultant/Advisory Board: ViraCor-IBT, Speaker: ALK-Abello; Honorarium: ALK-Abello, Thermo Fisher Scientific; Research Grant: Thermo Fisher Scientific

Jay M. Portnoy, MD, FACAAI

Consultant/Advisory Board: Sanofi, Thermo Fisher Scientific; Speaker: Mylan, Thermo Fisher Scientific; Honorarium: Mylan, Sanofi, Thermo Fisher Scientific

Marc A. Riedl, MD, MS

Consultant/Advisory Board: BioCryst, CSL Behring, Dyax, Shire, ViroPharma; Speaker: CSL Behring, Dyax, Shire, ViroPharma; Research Grant: CSL Behring, Dyax, Shire, ViroPharma

Ketan Sheth, MD, MBA, FACAAI

Consultant/Advisory Board: Teva; Speaker: GlaxoSmithKline, Teva; Honorarium: GlaxoSmithKline, Teva; Stocks: Merck

Charles J. Siegel, MD, FACAAI

Consultant/Advisory Board: Meda, Teva; Speaker: Meda, Teva; Honorarium: Meda, Mylan, Teva

David P. Skoner, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Merck, Sunovion; Speaker: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva; Research Grant: GlaxoSmithKline, Greer, Merck, Novartis, Teva

Brett E. Stanaland, MD, MS, FACAAI

Consultant/Advisory Board: Sunovion, Teva; Speaker: Meda, Merck, Sunovion, Teva

Gary C. Steven, MD, PhD, FACAAI

Speaker: Merck, Novartis, Teva; Research Grant: Merck, AstraZeneca, Circassia, Genentech, Mylan, Novartis, Novum, Optinose, Concentric, Pulmagen, GlaxoSmithKline, Teva

James L. Sublett, MD, FACAAI

Consultant/Advisory Board: Aerocrine, GlaxoSmithKline, Meda, Merck, Sunovion, Teva; Speaker: GlaxoSmithKline, Merck, Sunovion, Teva; Honorarium: GlaxoSmithKline, Merck, Sunovion, Teva; Research Grant: GlaxoSmithKline, Merck, Novartis, Sunovion, Teva,

Stanley J. Szefler, MD, FACAAI

Consultant/Advisory Board: Boehringer Ingelheim, GlaxoSmithKline, Merck, Roche; Speaker: Merck; Honorarium: Genentech; Research Grant: Boehringer Ingelheim, GlaxoSmithKline

Stephen A. Tilles, MD FACAAI

Consultant/Advisory Board: Bausch & Lomb, Hycor, Merck, Mylan, Sunovion

Janna M. Tuck, MD, FACAAI

Stocks: Advanced Cell Technology, Cel-Sci, Synergy

Dana V. Wallace, MD, FACAAI

Consultant/Advisory Board: Bausch & Lomb, Mylan, Sanofi, Sunovion, Teva

Richard W. Weber, MD, FACAAI

Consultant/Advisory Board: Genentech; Speaker: Merck; Research Grant: Novartis

The following have no relevant financial relationships to disclose:

Joseph A. Bellanti, MD, FACAAI

Monica Bhagat, MD

Christina Ciaccio, MD, FACAAI

John O. Clarke, MD

Vesselin Dimov, MD

Nemr S. Eid, MD

Shari M. Erickson, MPH

Alessandro Fiocchi, MD, FACAAI (SC)

Karen A. Freedle, MD, FACAAI

Curtis L. Hedberg, MD, FACAAI

Kirsi Jarvinen-Seppo, MD, PhD

John M. Kelso, MD, FACAAI

Tao T. Le, MD, MHS, FACAAI

Alnoor A. Malick, MD, FACAAI

Jennifer Mammen, MD

Bryan L. Martin, DO, FACAAI

Kathleen May, MD, FACAAI

Michael Nelson, MD, PhD, FACAAI

Myngoc T. Nguyen, MD, FACAAI

Richard A. Nicklas, MD, FACAAI

Maeve O'Connor, MD, FACAAI

Mark T. O'Hollaren, MD, FACAAI

Gurusher Panjrath, MD

Kavita Patel, MD

Joram S. Seggev, MD, FACAAI

Meagan Shepherd, MD

David R. Weldon, MD, FACAAI

Education Staff/Committee/Reviewers have no relevant financial relationships to disclose, except as may be listed above.

Available Credit

41.25 AMA PRA Category 1 Credit™
41.25 Attendance
13.50 MOC

Please login or create an account to take this course.

College Learning Connection - Allergy & Asthma Education Programs

Bookmark/Search this post

ACAAI 2016 Annual Scientific Meeting

ACAAI 2016 Annual Scientific Meeting

Target Audience

Learning Objectives

Available Credit

Search form

You are here

ACAAI 2016 Annual Scientific Meeting

ACAAI 2016 Annual Scientific Meeting

Target Audience

Learning Objectives

Available Credit